For example, a study in 2013 identified that GREM1 expression correlated with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors, suggestive of a tumor suppressor role for GREM1 [48]. Here, GREM1 is linked to pancreatic neuroendocrine tumor.